However, the aforementioned dual leptin roles have not yet been confirmed in the NAFLD population, and the exact mechanism remains unclear, so further large prospective research should be performed to validate these findings. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.